期刊文献+

182例糖尿病住院患者死因分析

暂未订购
导出
摘要 目的 :了解我院糖尿病住院患者病死率及主要死亡原因。方法 :回顾性分析我院 1990年至 2 0 0 3年住院的糖尿病患者死亡情况。结果 :14a中 ,糖尿病患者病死率 (6 .5 7% )明显高于非糖尿病住院患者 (2 .4 1% ) (P <0 .0 1) ,男性病死率 (6 .72 % )与女性病死率 (6 .39% )无显著差别 ,糖尿病患者前 5位死因顺序是 :心血管疾病、脑血管疾病、肿瘤、糖尿病肾病 (尿毒症 )、感染。死于心、脑等大血管并发症的比率为 4 2 .31% ,死于心、脑、肾并发症的病人中72 %合并高血压。结论 :心脑等大血管并发症是目前糖尿病患者最重要的死亡原因。高血压是其主要危险因素。严格控制高血糖的同时早期控制血压 ,对防治糖尿病并发症和降低病死率有重要意义。
出处 《实用医技杂志》 2004年第09B期1903-1904,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献3

二级参考文献12

  • 1UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macro-vascular and microvascular complication in type 2 diabetes: UKPDS 38. Br Meal J 1998 ;S17; 703-713.
  • 2Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-259.
  • 3Lewis EJ, Hunsicker LG, Bain PR, et al. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Eng J Med 1993;229:1456-1462.
  • 4Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes on patients with type 2 diabetes and nephropathy. N Engl J Meal 2001 ; 345 : 861-869.
  • 5Lewis E J, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathydue to type 2 diabetes, N Engl J Med 2001;345 : 851 - 860.
  • 6Nilsen FS, rossing P, Gell NA, et al. Long-term effect of Iisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nepbropatby. Diabetes 1977;46:1182-1188.
  • 7Blood pressure Lowering Treatment Trialist's Conaborarion: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;356:1955 - 1944.
  • 8Messerli FH: Implications of discontinuation of doxazosin arm of ALLHAT: the Antihypertensive and Lipid-Lowering Treatment to Provent Heart Attack Trial. Lancet 2000; 355;863 -864.
  • 9Mogensen CE, Meldam S, Tikkanen I, et al, Randomised controlled trial of dual blockade of renin-angiotension system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the Candesartan And Lisinopril Microalbuminuria(CALM)Study, BMJ 2000;321 : 1440- 1444.
  • 10Lindholm LH, Ibsen H, Dahlof B, Devereux RB, et al.Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervetion For Endpoint reduction in hypertension study(LIFE):a randomised trial against atenolol. Lancet 2002 Mar 23 ;359(9311) : 1004- 10.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部